Biogend Therapeutics Co Ltd
TPEX:6733
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogend Therapeutics Co Ltd
TPEX:6733
|
TW |
|
K
|
Kistron Co Ltd(Gyeonggi-do)
KOSDAQ:475430
|
KR |
|
A
|
Aker Technology Co Ltd
TPEX:6174
|
TW |
|
K
|
Korea No.12 Special Purpose Acquisition Co Ltd
KOSDAQ:458610
|
KR |
|
K
|
Kratos Defense and Security Solutions Inc
XMUN:WF5A
|
US |
|
Blumetric Environmental Inc
OTC:BLMWF
|
CA |
|
F
|
First Capital Securities Corporation Ltd
KAR:FCSC
|
PK |
Shareholder Yield
Current shareholder yield for Biogend Therapeutics Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Biogend Therapeutics Co Ltd
| Average Annual Return | 4.59% |
| Standard Deviation of Annual Returns | 42.24% |
| Max Drawdown | -52% |
| Market Capitalization | 3.3B TWD |
| Shares Outstanding | 134 320 000 |
| Percentage of Shares Shorted |
N/A
|
